What Dissociation Can Feel Like
Dissociation is a word that can sound more alarming than the experience itself. During ketamine treatment, dissociation can involve a temporary shift in how you experience yourself, your body, time, or the space around you. You may feel distant from your thoughts, less connected to your usual sense of identity, unusually still, or as if the room has become far away.
Some people describe it as floating. Others describe a dreamlike quality, a loosening of ordinary mental boundaries, or a sense that time has slowed down. The experience is personal, and it is not always easy to put into language while it is happening.
Ketamine can alter perception and produce dissociative effects, which is one reason careful medical oversight matters. Research on ketamine’s antidepressant mechanisms also describes its acute perceptual and dissociative effects (Alshammari, 2020). Those effects may be mild for one person and more noticeable for another.
Dissociation is not the same as losing control. It is also not a required part of a helpful experience. We do not frame intensity as a measure of value, and we do not ask patients to push through an experience that feels unsafe or overwhelming.
Why Ketamine May Alter Your Sense of Self or Surroundings
Ketamine affects the brain differently than conventional daily psychiatric medications. During a session, that change may briefly interrupt familiar patterns of attention, self-reference, sensation, and emotional response. The result can feel unusual because your ordinary way of organizing experience is temporarily less fixed.
Studies using brain imaging have found that ketamine is associated with changes in brain activity and connectivity during infusion. Simultaneous EEG and fMRI findings illustrate that these acute effects involve measurable shifts in neural signaling (McMillan et al., 2020). That does not mean any particular subjective experience is expected, or that a stronger experience is better.
The clinical conversation matters as much as the description. If you have a history of panic, trauma-related dissociation, psychosis, or periods of feeling detached from reality, we want to know that before treatment begins. These details help us consider whether ketamine therapy is appropriate and how to make a plan that respects your history.
Ketamine for psychiatric uses is off-label. That means it should be approached with individualized screening, informed consent, and follow-up rather than assumptions about what the experience will be like.
How We Talk About Dissociation Before a Session
We begin with the practical questions. What have you experienced before with medications, trauma, anxiety, sleep disruption, or substances? Have you ever felt unreal, disconnected from your body, or unsure whether your surroundings were real? What helps you regain your footing when you are distressed?
These are not questions designed to disqualify you for having a complicated history. They are questions that help us understand the context of your care.
We also explain what you may notice during treatment. A shift in sensory perception or emotional distance can be unsettling if it arrives without context. Knowing that you can communicate with the clinical team, and that the session is monitored, can make the experience less mysterious.
For patients exploring ketamine in the context of depression, our discussion may include the broader course of symptoms and prior care. You can learn more about ketamine for depression as part of that conversation. For patients living with trauma symptoms, we similarly take time to understand triggers, grounding skills, and support outside the treatment room. Our ketamine and PTSD care is built around that need for individualized attention.
What We Emphasize During and After Treatment
We emphasize preparation, observation, and honest follow-up. A ketamine session is not a test of your ability to have a profound experience. It is a clinical encounter, and your comfort, safety, and ability to communicate matter.
During treatment, we encourage patients to let us know if they feel frightened, physically uncomfortable, confused, or more detached than they expected. Sometimes reassurance and a calm reminder of where you are can be enough. Sometimes the treatment plan needs adjustment. We take both possibilities seriously.
Afterward, we ask about more than mood. We want to know whether you felt grounded again, whether the experience lingered in a distressing way, how you slept, and what support you have between visits. Research suggests ketamine’s short-term and longer-term effects on brain circuitry are not identical, which is one reason changes in brain connectivity over time should not be reduced to a single session experience (Gass et al., 2019).
Psychological support can be useful when an experience brings up difficult material or leaves you with questions. Our psychotherapy and coaching services can provide space to reflect, build grounding skills, and connect what happened in treatment to daily life. Medication history also remains important, which is why medication management may be part of a broader care plan when appropriate.
Dissociation, Safety, and the Details Worth Sharing
A brief altered sense of self or surroundings during a monitored session is different from severe or persistent disconnection afterward. Please tell us promptly if you experience ongoing confusion, distressing unreality, worsening agitation, urinary symptoms, or other changes that concern you.
Long-term or repeated ketamine exposure has also been associated with urinary tract concerns in some contexts. Clinical discussion of ketamine-associated uropathy underscores why dose, frequency, medical history, and emerging symptoms deserve attention (Andrade, 2025).
We also encourage patients not to treat dissociation as proof that treatment is working. Newer research is actively examining compounds designed to support neuroplasticity without the same dissociative effects, which reflects an ongoing scientific question about how these effects relate to clinical outcomes. Work on nondissociative neuroplastogens highlights that distinction (Agrawal et al., 2025).
Frequently Asked Questions
Is dissociation dangerous during ketamine therapy?
It can be uncomfortable, especially if it is unfamiliar or intense. In a properly screened and monitored setting, we address it as a clinical experience that deserves preparation and attention, not as something to dismiss. Severe, prolonged, or concerning symptoms should always be reported.
Will I definitely dissociate?
No. People respond differently to ketamine, and the character and intensity of an experience can vary across individuals and sessions. We cannot predict a specific subjective response.
Should I tell you if I have dissociated before?
Yes. Whether it occurred during trauma, panic, substance use, a medical event, or another period of stress, it is relevant to screening and treatment planning.
What if I am in crisis?
Ketamine treatment is not a substitute for immediate crisis care. If you are in immediate danger, call 911 or go to the nearest emergency department. You can also call or text 988 for the 988 Suicide and Crisis Lifeline (988 Suicide and Crisis Lifeline, n.d.).
Key Takeaways
Dissociation during ketamine therapy can involve a temporary altered sense of self, body, time, or surroundings. It may be noticeable, but it is not a requirement for benefit and should never be treated as a goal.
We believe the right approach is direct and unhurried. Tell us what you have experienced before. Tell us what worries you. Tell us what helps you feel grounded. Those details belong in screening, in the treatment room, and in follow-up.
If you are considering care in Johnson City or Clearwater and would like to talk through whether ketamine treatment may fit your circumstances, we invite you to contact our team at 888-214-2144 to schedule a consultation.
Medical Disclaimer
This article is for general educational purposes and is not medical advice. Ketamine for psychiatric uses is off-label, and eligibility requires an individual clinical evaluation. If you have urgent symptoms, thoughts of harming yourself, or concern that you cannot stay safe, call 911, visit the nearest emergency department, or contact 988.
Works Cited
1. Alshammari TK. The Ketamine Antidepressant Story: New Insights. https://pubmed.ncbi.nlm.nih.gov/33297563/
2. McMillan R, et al. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder. https://pubmed.ncbi.nlm.nih.gov/31843628/
3. Gass N, et al. Differences between ketamine’s short-term and long-term effects on brain circuitry in depression. https://pubmed.ncbi.nlm.nih.gov/31253763/
4. Andrade C. Ketamine-Associated Uropathy During Therapeutic and Nontherapeutic Use: Prevalence, Clinical Features, Mechanisms, and Strategies for Risk Reduction. https://pubmed.ncbi.nlm.nih.gov/40965833/
5. Agrawal R, et al. Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics. https://pubmed.ncbi.nlm.nih.gov/41078264/
6. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.
